Treatment of essential tremor with the barbiturate T2000 (1,3-Dimethoxymethyl-5,5-diphenyl-barbituric acid)

Movement Disorders

Volumn 22, Issue 5, 2007, Pages 723-727

  Melmed, Calvin ^a,b   Moros, Daniel ^c,d   Rutman, Howard ^c,e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Taro Pharmaceuticals   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Barbiturate; Dimethoxymethyl diphenyl barbituric acid; Essential tremor; T2000

Indexed keywords

1,3 DIMETHOXYMETHYL 5,5 DIPHENYLBARBITURIC ACID; BARBITURIC ACID DERIVATIVE; DIPHENHYDRAMINE; PLACEBO; T 2000; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG USE; DRUG WITHDRAWAL; ESSENTIAL TREMOR; FEMALE; FEVER; HUMAN; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; BARBITURATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PHENOBARBITAL;

EID: 34249060911     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21321     Document Type: Article

References (18)

1. Findley LJ. The pharmacology of essential tremor. In: Marsden CD, Fahn S, editors. Movement Disorders, 2nd ed. London: Butterworths; 1987. pp 438-458.
2. Koller WC, Biary N. Effect of alcohol on tremor: comparison to propranolol. Neurology 1984;34:221-222.
3. Young RR, Growdon JH, Shahani BT. β-adrenergic mechanism in essential tremor. N Eng J Med 1975;293:250-253.
4. Koller WC, Hristova A, Brin M. Pharmacologic treatment of essential tremor. Neurology 2000;54(Suppl. 4):S30-S38.
5. Findley LJ, Cleeves L, Caletti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry 1985;48:911-915.
6. Koller WC, Royce V. Efficacy of primidone in essential tremor. Neurology 1986;36:121-124.
7. Gironell A, Kulisevsky J, Lopez-Villegas D, Hernandez G, Pascual-Sedano B. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 1999;56:475-480.
8. Conner GS. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology 2002;59:132-134.
9. Findley LJ, Cleeves L. Phenobarbital in essential tremor. Neurology 1988;38:1784-1787.
10. Shill HA, Bushara KO, Mari Z, et al. Open-label dose-escalation study of oral 1-octanol in patients with essential tremor. Neurology 2004;62:2320-2322.
11. Raines A, Baumel I, Gallagher BB, et al. The effects of 5,5-diphenylbarbituric acid on experimental seizures in rats: correlation between plasma and brain concentrations and anticonvulsant activity. Epilepsia 1975;16:575-581.
12. Raines A, Blake GJ, Richardson B, et al. Differential selectivity of several barbiturates on experimental seizures and neurotoxicity. Epilepsia 1979;20:105-113.
13. Raines A, Flockhart DA, Dretchen KL, et al. Serum and brain levels of 5,5-diphenylbarbituric acid (DPB) after administration of dimethoxymethyl- diphenyl-barbituric acid (T2000) in the rat. Epilepsia 1996;37(Suppl. 6):23.
14. Wolf HH, White HS, Franklin MR, et al. A preclinical evaluation of the potential antiepileptic utility of ADD 261007. Report from the Anticonvulsant Screening Project of the Epilepsy Branch, Neurology Disorders Program, National Institute of Neurological Disorders and Stroke. Data on File with Company 1988.
15. Jankovic J. Essential tremor: clinical characteristics. Neurology 2000;54(Suppl. 4):S21-S25.
16. Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, editors. Parkinson's Disease and Movement Disorders. Munich: Urban and Schwarzenberg; 1988. pp 225-242.
17. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: Wiley; 1986.
18. SAS Institute Inc. SAS/STAT User's Guide, Version 82.